In January, the United States also withdrew its emergency use authorization for the drug. At the time, the Food and Drug Administration (FDA), an agency equivalent to Anvisa, stated that the drug did not neutralize omicron subvariants, as is the case with XBB.1.5.1, prevalent in the country.
President Luiz Inácio Lula da Silva (PT) was vaccinated against dengue fever on February 5, without publicity and before the...
The damage caused to hair strands due to hair transformation is something that worries most people, often discouraging them from...
Last week, the National Supplementary Health Agency (ANS) authorized Golden Cross to suspend the sale of 114 of the operator's...
Have you ever found yourself deeply questioning the purpose of your life, your choices and the meaning of existence? If...
